Veeva Systems stock
Price history
+3.37% over the period1 year: from $291.70 (November 13, 2025) to $301.53 (November 13, 2026), +3.37%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $301.53 |
| October 30, 2026 | $312.96 |
| September 30, 2026 | $285.45 |
| August 31, 2026 | $285.69 |
| July 31, 2026 | $203.78 |
| June 30, 2026 | $177.47 |
| May 29, 2026 | $174.34 |
| April 30, 2026 | $155.97 |
| March 31, 2026 | $175.66 |
| February 27, 2026 | $182.01 |
| January 30, 2026 | $203.92 |
| December 31, 2025 | $223.23 |
| November 28, 2025 | $240.29 |
| November 13, 2025 | $291.70 |
At a glance
The company
Provides cloud-based software for life sciences including CRM, clinical trial management, regulatory information, and quality management solutions
Latest results
Quarter to July 31, 2026 · EPS $2.35 (estimate $2.22)
Next event
TickerLandia's take on Veeva Systems
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 55 vs a median of 69 over its last 10 fiscal years.
- Strong point: Financial strength (93/100 in its group). Weak point: Earnings stability (36/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−7.50% from the 52-week high
Analysts · 29 analysts
Average target$326.41+8.25% vs. price
Buy 20 · Hold 8 · Sell 1 · Buy
TickerLandia Fingerprint: Veeva Systems
Compared with similar companies: very high financial strength, very high price, and very high profitability.
Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery high86
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 49.4 89 Forward P/E 29.4 84 Price/book 6.57 76 Price/sales 14.1 90 EV/EBITDA 38.8 91 Profitabilityvery high84
How much it earns on revenue and capital.
Metric Value Position in group ROE 14.4% 59 ROA 7.6% 74 Gross margin 75.0% 92 Net margin 29.3% 97 Operating margin 29.9% 97 Earnings stabilitylow36
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 4.3% 13 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Growthhigh73
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) +39.50% 75 Revenue growth (year over year) +17.60% 78 Average revenue growth (3 years) +14.03% 65 Financial strengthvery high93
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −1.35 99 Current ratio 5.46 92 Debt/equitycounts in reverse: lower means more financial strength 0.02 87 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery strong82
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (6 months) +90.62% 99 Relative strength (3 months) +23.10% 94 1-year return +3.37% 36 Distance from 200-day average +41.21% 99 Riskhigh63
How much the price swings.
Metric Value Position in group Beta (1 year) 0.52 41 Volatility (60 days) 40.6% 64 Maximum drawdown (12 months) 48.4% 83
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Veeva Systems is cheaper than in the past and in line with similar companies
On the latest fiscal year's earnings (2026), Veeva Systems's P/E today is 55.4, below the median of its last 10 fiscal years (69.3; between 37.5 and 117.1 from 2017 to 2026). Veeva Systems's Forward P/E: 29.4, in line with the median of a group of 5 similar companies (29.4).
Compared with 5 similar companies
| Metric | Veeva Systems | Position in the group | Band |
|---|---|---|---|
| Forward P/E | 29.4 | Middle | |
| Operating margin | 29.9% | High | |
| ROE | 14.4% | High | |
| Debt/equity | 0.02 | Middle | |
| Price/book | 6.57 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Veeva Systems. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$927.96M
Latest quarter · Q to Jul 2026
Net income
$273.43M
Latest quarter · Q to Jul 2026
Quarterly net margin
29.5%
Latest quarter · Q to Jul 2026
Numbers and valuation
Full valuation- Market cap
- $48.82B
- P/E
- 49.4
- EPS
- $6.10
- Volume
- 737.3K
- Daily trading
- €388.17M
- Dividend yield
- 0.00%
How Veeva Systems is changing
All resultsRevenue grew 16.9% a year on average over the last 5 years
Operating margin rose from 21.3% to 28.7%
Profits turn into cash: free cash flow equal to 155% of net income
Returns
Veeva Systems returns
$1,000 invested in Veeva Systems 5 years ago, on November 15, 2021, would be worth $956 today: −4.44% in total, −0.91% per year. This is the price return only: dividends are excluded.
| Period | Veeva Systems | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | −0.03% | −3.12% | $1,000 |
| 6 months | +93.62% | +1.58% | $1,936 |
| Year to date | +35.08% | +10.46% | $1,351 |
| 1 year | +3.37% | +12.23% | $1,034 |
| 3 years | +81.37% | +71.41% | $1,814 |
| 5 years | −4.44% | +61.48% | $956 |
| 10 years | +655.71% | +249.40% | $7,557 |
Over the last 6 months it has done better than 97% of the stocks in the Healthcare sector.
Price only, without dividends. Calculate your investment
The chart in detail
Veeva Systems: technical analysis
Veeva Systems is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 11.6% below its all-time closing high ($341.00, August 5, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 49
- Between 30 and 70
- vs 200-session average
- +41.21%
Active signals
The price is moving in an unusually narrow range compared with the last year.
since November 5, 2026
Support and resistance
Price areas where Veeva Systems has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$301.53
- Support$294.21−2.43%3 touches, last on November 6, 2026
- Support$246.03−18.41%2 touches, last on January 9, 2026
- Support$236.71−21.50%2 touches, last on August 26, 2026
Volatility and risk
Over the last year it has moved less than the S&P 500.
- Beta (1 year) vs S&P 500
- 0.52
- Volatility (60 sessions, annualised)
- 40.6%
- Largest fall in the last year
- −48.38%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Veeva Systems: seasonality
Average monthly price change over 13 years
Over the last 13 years, the strongest month for Veeva Systems has been August: +7.95% on average, positive in 7 years out of 13. The weakest has been December: −8.05% on average, positive in 1 years out of 13. November, the current month, has been positive in 9 years out of 13 (+3.39% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +3.49% | +4.23% | 9 of 13 |
| February | +2.12% | +1.33% | 8 of 13 |
| March | +0.07% | +3.09% | 8 of 13 |
| April | −1.13% | +0.89% | 7 of 13 |
| May | +7.18% | +10.31% | 10 of 13 |
| June | +6.81% | +5.03% | 11 of 13 |
| July | +4.62% | +4.00% | 9 of 13 |
| August | +7.95% | +2.19% | 7 of 13 |
| September | −3.56% | −3.04% | 3 of 13 |
| October | +0.20% | −0.50% | 6 of 13 |
| November | +3.39% | +5.18% | 9 of 13 |
| December | −8.05% | −7.72% | 1 of 13 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Veeva Systems and its competitors
With 7,928 employees, the company builds cloud software for pharmaceutical, biotechnology and other life sciences firms. Its applications cover commercial operations, from CRM and promotional content management to medical content and customer data, as well as clinical trial execution, drug safety, regulatory information management and quality systems. Services include implementation, data migration, systems integration, training and outsourced administration. Its customers include pharmaceutical and biotechnology companies as well as other life sciences firms.
- Headquarters
- Pleasanton, United States
- Employees
- 7,928
- Founded
- 2007
- Chief executive
- Peter Gassner
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Veeva SystemsVEEV | $48.82B | 29.9% | 49.4 | +93.62% |
| Tempus AITEM | $13.06B | -18.5% | — | +55.99% |
| DoximityDOCS | $5.95B | 27.1% | 46.3 | +42.54% |
| Pro MedicusPME | $14.57B | 74.9% | 81.4 | +65.15% |
| M32413 | $7.61B | 19.5% | 26.5 | +34.35% |
| XtalPi Holdings2228 | $3B | -124.6% | — | −32.46% |
Same industry or related industries, similar size. Compare Veeva Systems with its competitors · Full profile
